A randomized controlled, open-labelled early phase II trial comparing incidence of FOLFIRI.3-induced diarrhea between Hangeshashinto and oral alkalization in Japanese patients with colorectal cancer

ABSTRACT: Interventions: Hangeshashinto(TJ-14) Oral alkalization Primary outcome(s): the incidence of all grade of a late-onset diarrhea during the treatment period Study Design: Parallel Randomized

DISEASE(S): Colorectal Cancer

PROVIDER: 2639470 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR